Global Gastric Cancer Therapy Market - Segmented by Therapy Type, End-User, and Geography - Growth, Trends, and Forecast (2022 - 2030)

The global gastric cancer therapy market is expected to register a CAGR of 13.0% during the forecast period (2018 - 2023). Asia Pacific dominates the market, due to the growing incidence of gastric cancer in that region.

Growing Incidence of Gastric Cancer

According to a report published by Indian Council of Medical Research in 2014, gastric cancer is the fourth leading cancer in the world, accounting for 736,000 deaths. Around 1 million new cases of gastric cancer and 0.7 million deaths due to gastric cancer are reported every year. Age-standardized incidence rates are approximately twice as high in men as in women. Presently, gastric cancer is more common in Asia, than in the United States or Europe. Notably, 42% of cases occur in China alone.
Thus, increasing incidence of gastric cancer, coupled with strong drug pipeline, and introduction of novel therapies for metastatic stomach cancer, across the world, are likely to drive the market for gastric cancer therapy.

High Cost of Cancer Therapy and Side Effects of Cancer Drugs

The global cost of cancer therapy and drugs increased from USD 91 billion to USD 113 billion, in 2016. High cost of therapy and adverse events associated with the existing cancer drugs, for treatment of stomach cancer, may hinder the global stomach cancer market. The serious side effects associated with the usage of drugs include autoimmune reactions and infusion reactions. Additionally, a large patient pool undiagnosed with gastric cancer and the lack of awareness regarding gastric cancer are likely to impede the growth of the global cancer therapy market.

Asia-Pacific to Dominate the Market

Asia-Pacific dominates the global gastric cancer therapy market, owing to high incidence of stomach cancer in that region. China is expected to show a tremendous growth for this market, during the forecast period, owing to factors, such as high prevalence of obesity, and growing awareness about diabetes care. The growing incidence of gastric cancer in China is followed by Japan and Korea. China accounts for over 40% of all new gastric cancer cases in the world, which will drive the market for gastric cancer therapy in China.

Key Developments in the Market

• February 2018: Imugene, an immune oncology company announced that its cancer vaccine yields promising results in gastric cancer clinical trial studies.
• September 2017: The Food and Drug Administration (FDA) approved the immunotherapy drug pembrolizumab(Keytruda®) to be used on patients with advanced gastric (stomach) cancer.

Major Players: BRISTOL-MYERS SQUIBB, ELI LILLY AND COMPANY, F. HOFFMANN-LA ROCHE LTD, GLAXOSMITHKLINE PLC, IMUGENE LIMITED, MERCK KGAA, NOVARTIS AG, ONO PHARMACEUTICALS, OTSUKA HOLDINGS CO. LTD, AND SANOFI amongst others.

Reasons to Purchase the Report

• Current and future market outlook for gastric cancer therapy in the developed and emerging markets
• Analyse various perspectives on the market, with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth, during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 month analyst support, along with the market estimate sheet (in Excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports